检索结果 - Carl Vance
- Showing 1 - 1 results of 1
-
1
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial 由 W. Timothy Garvey, Juan P. Frías, Ania M. Jastreboff, Carel W. le Roux, Naveed Sattar, Diego Aizenberg, Huzhang Mao, Shuyu Zhang, Nadia N. Ahmad, Mathijs C. Bunck, Imane Benabbad, X. Zhang, Franklin Ábalos, Federico C. Pérez Manghi, Cesar Javier Zaidman, Marisa L. Vico, Diego Aizenberg, P. Costanzo, L. Serra, Ignacio MacKinnon, Miguel Nasser Hissa, Maria H Vidotti, José Francisco Kerr Saraiva, Breno B. Alves, Denise Reis Franco, Otavio Moratto, Sreenivasa Murthy, Ghanshyam Goyal, Yoshimitsu Yamasaki, Nobuyuki Sato, Satoshi Inoue, Taro Asakura, Marina V. Shestakova, Elena Khaykina, Е. А. Трошина, Н. В. Ворохобина, Ametov As, Shih‐Te Tu, Chwen-Yi Yang, I‐Te Lee, Chien‐Ning Huang, Horng‐Yih Ou, George Freeman, Sriram Machineni, Klara R. Klein, Senan Sultan, Alan A. Parsa, Juan Otero-Martinez, Alex Gonzalez, Anuj Bhargava, Susan Brian, Carlos Ince, Stephen Plantholt, Jeremy Cole, Audrey Lacour, Damaris Vega, José de Souza, Jane L. Rohlf, Roy C. St. John, Barry Horowitz, Hanid Audish, Rodolfo J. Galindo, Guillermo Umpiperrez, Jamy D. Ard, Brian R. Curtis, W. Timothy Garvey, Neil J. Fraser, Jose Mandry, Rizwana Mohseni, Ronald K. Mayfield, Talessa Powell, Carl Vance, Stephen Ong, Ana L. Lewy-Alterbaum, Alexander V. Murray, Amer Al‐Karadsheh, Tamer Yacoub, Kevin Roberts, David L. Fried, Julio Rosenstock, Bharathi Pulla, Bruce W. Bode, Juan P. Frías, Leslie J. Klaff, Ronald Brazg, Joanna Van, Anjanette Tan, Toby Briskin, Margaret Rhee, Tira Chaicha-Brom, Paul Hartley, Lazaro Nunez, Gregorio Cortes-Maisonet, Gary Soucie, Stanley H. Hsia, Thomas C. Jones
出版 2023Artigo
相关主题
Alternative medicine
Body mass index
Clinical endpoint
Diabetes mellitus
Discontinuation
Endocrinology
Environmental health
Intention-to-treat analysis
Internal medicine
Medicine
Obesity
Overweight
Pathology
Physical therapy
Placebo
Population
Randomized controlled trial
Regimen
Type 2 diabetes
Weight loss